We further show that in AD, low RAP levels are associated with high Aβ and tau (soluble and insoluble tau protein) pathologies, suggesting that RAP may play a role in the disease process and highlight the need for further research in this area. This evidence concerns the gene MAPT and Alzheimer disease.